FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:868 March 24, 1994 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: We report two cases of uveitis associated with rifabutin therapy. A 52-year-old woman with pulmonary Mycobacterium avium complex infection who was negative for the human immunodeficiency virus was referred to our clinic in October 1992 after being treated with several antimicrobial regimens without improvement. With a regimen of clarithromycin, ethambutol, and rifampin, fever and night sweats resolved and cough and dyspnea improved greatly. In May 1993 the patient's respiratory symptoms worsened, and on June 10, 1993, rifampin was discontinued and treatment with rifabutin at a daily dose of 600 mg was initiated. Because of low-grade fever, ciprofloxacin . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Vaudaux, J. D., Guex-Crosier, Y. (2002). Rifabutin-induced cystoid macular oedema. J Antimicrob Chemother 49: 421-422 [Abstract] [Full Text]  
• Hafner, R., Bethel, J., Power, M., Landry, B., Banach, M., Mole, L., Standiford, H. C., Follansbee, S., Kumar, P., Raasch, R., Cohn, D., Mushatt, D., Drusano, G. (1998). Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers. Antimicrob. Agents Chemother. 42: 631-639 [Abstract] [Full Text]